Krystal Biotech, Inc. (KRYS)

Krystal Biotech Revenue

In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth. Krystal Biotech had revenue of $91.14M in the quarter ending December 31, 2024, with 116.26% growth.

• Revenue (ttm): $290.52M
• Revenue Growth: +473.02%
• P/S Ratio: 18.49
• Revenue / Employee: $1,268,624
• Employees: 229
• Market Cap: 5.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.52M	239.82M	473.02%
Dec 31, 2023	50.70M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.